Gossamer Bio
GOSS
GOSS
95 hedge funds and large institutions have $171M invested in Gossamer Bio in 2023 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 31 increasing their positions, 19 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 34
4% less funds holding
Funds holding: 99 → 95 (-4)
Holders
95
Holding in Top 10
1
Calls
$2.67M
Puts
$538K
Top Buyers
| 1 | +$10.2M | |
| 2 | +$7.66M | |
| 3 | +$6.71M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.4M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$5.67M |
Top Sellers
| 1 | -$1.58M | |
| 2 | -$1.49M | |
| 3 | -$1.27M | |
| 4 |
Two Sigma Investments
New York
|
-$861K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$582K |